PV International Desk : The US authorities have given anti-malaria drugs a limited approval for treatment of coronavirus infection.

The Food and Drug Administration issued the emergency-use authorisation for two antimalarial drugs to treat the COVID-19 patients as the country, like most others, is struggling to fight with the pandemic.

The US Department of Health and Human Services announced it had received 30 million doses of hydroxychloroquine sulfate and one million doses of hloroquine phosphate donated to a national stockpile of potentially life-saving pharmaceuticals and medical supplies, ABC News reported citing a statement released on Sunday.

Hydroxychloroquine and chloroquine, which are oral prescription drugs used primarily to prevent and treat malaria, are both being investigated as potential therapeutics for COVID-19, according to the report.